DUSA Pharmaceuticals (DUSA)
DUSA Pharmaceuticals Beneish M-Score: -2.563
View DUSA Beneish M-Score with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
DUSA Beneish M-Score Rankings
| Overall | 46th percentile | 2013 of 3761 |
| Sector | 52nd percentile | 161 of 342 in Healthcare |
| Industry | 72nd percentile | 6 of 22 in Drug Manufacturers - Other |
DUSA Beneish M-Score Range, Past 5 Years
| Minimum | -3.271 | Dec 2008 |
| Maximum | -2.390 | Dec 2010 |
| Average | -2.705 |
About Beneish M Score
The Beneish M Score helps to uncover companies who are likely to be manipulating their reported earnings. Companies with a higher score are more likely to be manipulators. This is a probabilistic model, so it will not detect manipulators with 100% accuracy.
The best cut-off point depends on the costs mistakenly classifying in one of two ways:
1) Classifying firm that is manipulating earnings as a non-manipulator (Type I error), and
2) Classifying a firm as a manipulator when it actually was not manipulating (Type II Error).
Here are optimal cut-offs according to Beneish, presented as the score followed by the cost of Type I error relative to cost of Type II error):
M Score HTML Table:
| Score | Relative Error Costs (Type I:Type II) |
|---|---|
| M Score > -1.49 | (10:1) | M Score > -1.78 | (20:1) | M Score > -1.89 | (40+:1) |
Beneish excluded financial institutions from his sample when calculating the M-Score, so extreme care should be taken when looking at M-Scores of financial firms - their business models are different from the manufacturing and other service firms that Beneish used in his study.
If you want more details, here is the original Beneish M Score Paper, or you can learn about our calculation by clicking "Learn More" below.
Learn More
You may also be interested in these DUSA related companies
DUSA News
$DUSA - Initial Stop hit. Trade close @ Initial Stop of $5.10 - http://stks.co/3so5
about 12 days ago by TraderFoxxx
about 12 days ago by TraderFoxxx
$DUSA forms bearish "Diamond Top" chart pattern. http://stks.co/3mUY
about 18 days ago by RecogniaEvents
about 18 days ago by RecogniaEvents
Listen to $DUSA Q1 2012 earnings call - live at 08:30 AM, ondemand after - http://stks.co/3iR7
about 21 days ago by earningscast
about 21 days ago by earningscast
DUSA Pharmaceuticals Reports First Quarter 2012 Corporate Highlights and Financial Results
May 08, 6:30AM GlobeNewswire
May 08, 6:30AM GlobeNewswire
DUSA Pharmaceuticals Completes Enrollment in Phase 2 Studies of Levulan(R) Kerastick(R) Photodynamic Therapy
Apr 24, 7:30AM GlobeNewswire
Apr 24, 7:30AM GlobeNewswire
DUSA Pharmaceuticals Introduces Teeing Off Against Sun Damage(TM) Campaign to Raise Awareness of Actinic Keratosis
Apr 10, 8:30AM GlobeNewswire
Apr 10, 8:30AM GlobeNewswire
Trade Signal-New $DUSA -BTO @ 6.48-Limit w/5.10-Stop on the Wkly Chart w/.5N @ Risk http://chart.ly/t5llhwx
about 64 days ago by TraderFoxxx
about 64 days ago by TraderFoxxx
DUSA Pharmaceuticals to Present at the 2012 Maxim Group Growth Conference
Mar 23, 8:00AM GlobeNewswire
Mar 23, 8:00AM GlobeNewswire
$DUSA http://stks.co/2wc5 broke over lower range on volume of 150% of full day average - has a level overhead
about 71 days ago by StockTiger
about 71 days ago by StockTiger
DUSA Pharmaceuticals to Present at the 2012 Maxim Group Growth Conference
Mar 19, 8:30AM GlobeNewswire
Mar 19, 8:30AM GlobeNewswire
DUSA Pharmaceuticals to Present at Roth Capital Partners 24th Annual OC Growth Stock Conference
Mar 07, 8:30AM GlobeNewswire
Mar 07, 8:30AM GlobeNewswire
Listen to $DUSA Q4 2011 earnings call - live at 08:30 AM, ondemand after - http://stks.co/2giF
about 84 days ago by earningscast
about 84 days ago by earningscast
DUSA Pharmaceuticals Reports Full Year 2011 Corporate Highlights and Financial Results
Mar 06, 6:30AM GlobeNewswire
Mar 06, 6:30AM GlobeNewswire
DUSA Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference
Feb 08, 8:30AM GlobeNewswire
Feb 08, 8:30AM GlobeNewswire
DUSA Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference
Feb 06, 9:10AM GlobeNewswire
Feb 06, 9:10AM GlobeNewswire
DUSA Pharmaceuticals, Inc. (DUSA) CEO to Ring The NASDAQ Stock Market Opening Bell
Dec 21, 12:20PM GlobeNewswire
Dec 21, 12:20PM GlobeNewswire
DUSA Pharmaceuticals Reports Third Quarter 2011 Corporate Highlights and Financial Results
Nov 10, 6:30AM GlobeNewswire
Nov 10, 6:30AM GlobeNewswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| DUSA | 5.44 | +0.04 | +0.74% | 134.10M |
| DUK | 21.96 | +0.16 | +0.73% | 29.38B |
| DUG | 27.46 | +0.20 | +0.73% | |
| DUF | 14.83 | -0.07 | -0.47% | 515.79M |
| DUCK | 8.11 | +0.09 | +1.12% | 31.14M |
| DUC | 12.40 | +0.06 | +0.49% | |
| DTV | 46.40 | +0.03 | +0.06% | 31.39B |
| DRH | 9.85 | -0.01 | -0.10% | 1.661B |
| DRE | 13.72 | -0.07 | -0.51% | 3.569B |
| DRD | 6.24 | +0.06 | +0.97% | 240.18M |